Full Archive

A bad penny

Before we get into the gist of today’s post some well-earned shameless self-promotion as yes, a new day has dawned as www.thediabetesway.com went live today. Thanks to my excellent team and founding sponsors our wacky world is being turned upside down in a very positive way. The Diabetes Way is taking diabetes out of the clinic by focusing on the lifestyle of diabetes NOT the management of diabetes. What you...

A New Paradigm

In just under a week Diabetic Investor will be launching our most ambitious project www.thediabetesway.com. Starting January 19th, we will turn the diabetes world upside down as finally diabetes will be talked about not as chronic condition but as a lifestyle. My partner in this exciting new venture is Amber Clour from the www.diabetesdailygrind.com. Together Amber and I will do something that’s never been done before and to my knowledge...

Buy – Sell – Short

Over the years Diabetic Investor has been reluctant to make specific recommendations on when to buy, sell or short a company. Yes, we have ventured down this path and thankfully more often than not our recommendations have yielded a handsome profit. Yet unlike a traditional analyst or stock picker we pay more attention to who’s running the company and the market it plays in than the day-to-day financials. As we...

CES/JPM

The first thing we can say about the recent CES show in Vegas is this year’s show was a mere shell of its former self. Just by way of comparison back in 2019 before Covid over 300,000 people were in attendance. This year the expected attendance was pegged at around 75,000 and judging by the empty booths in the exhibit halls we’d say that was a very generous estimate. It’s...

The third option?

Way back in the day when it was becoming obvious that Dexcom and Abbot were going to rule the CGM world we speculated about who would be the third option. Our thought was the CGM market was developing along the same path as the BGM market albeit at a much faster pace. Back in the day LifeScan, Roche, Abbott and Bayer effectively controlled 90% of the BGM market with LifeScan...

New year same …..

There’s an old saying that if a tree falls in the forest when no one is around does anyone hear the sound? That’s almost how we’re approaching CES which for us begins Thursday afternoon. This year’s show is live or should we say as live as can be expected in the age of Covid. According to show officials there are over 2200 exhibitors with expected attendance of approximately 75,000 masked...

What was that ….

As 2021 draws to a close it’s difficult not to look back and think what a crazy year this has been. Not sure how many of us felt that Covid would still be hanging around, but it is and it’s having a major impact on every aspect of our lives. First it was Delta, now Omnicron and next who knows. About all we know for sure is 2022 will start...